Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2005
11/10/2005WO2005105781A1 Imidazole derivatives used as tafia inhibitors
11/10/2005WO2005105778A2 4-amino-5-cyanopyrimidine derivatives
11/10/2005WO2005105765A1 Nitric oxide donors and uses thereof
11/10/2005WO2005105763A1 Substituted morpholine compounds for the treatment of central nervous system disorders
11/10/2005WO2005105761A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
11/10/2005WO2005105748A1 4-halogenalkylpyridin-3-sulphonamides, method for producing same, agents containing same, and use thereof as agents for pest control
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105065A2 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
11/10/2005WO2005095390A3 Novel co-precipitate of amorphous rosiglitazone
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005WO2005082858A3 Isoquinoline derivatives
11/10/2005WO2005077124A3 Compounds and compositions as lxr modulators
11/10/2005WO2005075429B1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/10/2005WO2004099155A3 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/10/2005US20050250829 Kinase inhibitors
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005US20050250823 Gyrase inhibitors
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250786 PNA monomer and precursor
11/10/2005US20050250785 PNA monomer and precursor
11/10/2005US20050250784 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine;antiprolifrative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype;
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005US20050250781 (1-piperidine-3-cyclopentane)-amide derivatives; antiinflammatory agent, antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
11/10/2005US20050250777 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
11/10/2005US20050250776 ethyl (2-{[(2,4-dichloro-5-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetate; treatment of diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, without causing hypoglycemia
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050249668 Nir-fluorescent cyanine dyes, their synthesis and biological use
11/10/2005CA2565665A1 Synthesis of antidiabetic rosiglitazone derivatives
11/10/2005CA2565024A1 Therapeutic agent for left ventricular diastolic dysfunction
11/10/2005CA2564994A1 Substituted morpholine compounds for the treatment of central nervous system disorders
11/10/2005CA2564175A1 Chemical compounds
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592688A2 Polymorphic form b2 of ziprasidone base
11/09/2005EP1592686A1 Gyrase inhibitors and uses thereof
11/09/2005EP1592673A2 Novel substituted 2,3-benzodiazepine derivatives
11/09/2005EP1592403A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1320611B1 Heterologous production of polyketides
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP0873326B1 Process for preparing 2-chlorothiazole compounds
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/08/2005US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962935 Anticoagulants; thrombosis therapy; cardiovascular disorders
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962932 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005CA2249222C Aminopyridine derivatives
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103045A1 Acyl dihydro pyrrole derivatives as hcv inhibitors
11/03/2005WO2005103043A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer’s disease
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103034A1 Novel piperidine substituted diaminothiazoles
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005103006A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005WO2005102381A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
11/03/2005WO2005101989A2 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005WO2005011611A3 Bicyclic compounds and compositions as pdf inhibitors
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005WO2004106304A3 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
11/03/2005WO2004096131A3 Inhibitors of akt activity
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245588 Octahydro-2-h-naphtho[1,2-f]indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245579 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245547 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245530 Monocyclic heterocycles as kinase inhibitors
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245519 Substituted morpholine compounds for the treatment of central nervous system disorders
11/03/2005US20050245515 Indolyl derivatives as liver-X-receptor (LXR) modulators
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245458 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563639A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer~s disease
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2562377A1 Novel piperidine substituted diaminothiazoles
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005CA2560373A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 628